The Beauty Health Company (SKIN)

USD 0.95

(6.29%)

EBITDA Summary of The Beauty Health Company

  • The Beauty Health Company's latest annual EBITDA in 2023 was -56 Million USD , down -445.97% from previous year.
  • The Beauty Health Company's latest quarterly EBITDA in 2024 Q2 was -13.19 Million USD , up 8.5% from previous quarter.
  • The Beauty Health Company reported an annual EBITDA of 80.74 Million USD in 2022, up 81.0% from previous year.
  • The Beauty Health Company reported an annual EBITDA of -344.43 Million USD in 2021, down -3018.42% from previous year.
  • The Beauty Health Company reported a quarterly EBITDA of -13.19 Million USD for 2024 Q2, up 8.5% from previous quarter.
  • The Beauty Health Company reported a quarterly EBITDA of -7.4 Million USD for 2023 Q2, up 40.8% from previous quarter.

Annual EBITDA Chart of The Beauty Health Company (2023 - 2018)

Historical Annual EBITDA of The Beauty Health Company (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -56 Million USD -445.97%
2022 80.74 Million USD 81.0%
2021 -344.43 Million USD -3018.42%
2020 -2.8 Million USD -110.14%
2019 27.89 Million USD 29.38%
2018 21.55 Million USD 0.0%

Peer EBITDA Comparison of The Beauty Health Company

Name EBITDA EBITDA Difference
European Wax Center, Inc. 65.03 Million USD 186.112%
Helen of Troy Limited 301.32 Million USD 118.585%
Inter Parfums, Inc. 268.71 Million USD 120.84%
Mannatech, Incorporated 664 Thousand USD 8533.886%
Newell Brands Inc. 107 Million USD 152.337%
Tantech Holdings Ltd 8.25 Million USD 778.77%
Yoshitsu Co., Ltd 1.89 Billion USD 102.962%
United-Guardian, Inc. 2.96 Million USD 1986.372%